Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots
- PMID: 21271270
- PMCID: PMC3132383
- DOI: 10.1007/s10096-011-1157-6
Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots
Abstract
We investigated the influence of assay choice on the results in a two-tier testing algorithm for the detection of anti-Borrelia antibodies. Eighty-nine serum samples from clinically well-defined patients were tested in eight different enzyme-linked immunosorbent assay (ELISA) systems based on whole-cell antigens, whole-cell antigens supplemented with VlsE and assays using exclusively recombinant proteins. A subset of samples was tested in five immunoblots: one whole-cell blot, one whole-cell blot supplemented with VlsE and three recombinant blots. The number of IgM- and/or IgG-positive ELISA results in the group of patients suspected of Borrelia infection ranged from 34 to 59%. The percentage of positives in cross-reactivity controls ranged from 0 to 38%. Comparison of immunoblots yielded large differences in inter-test agreement and showed, at best, a moderate agreement between tests. Remarkably, some immunoblots gave positive results in samples that had been tested negative by all eight ELISAs. The percentage of positive blots following a positive ELISA result depended heavily on the choice of ELISA-immunoblot combination. We conclude that the assays used to detect anti-Borrelia antibodies have widely divergent sensitivity and specificity. The choice of ELISA-immunoblot combination severely influences the number of positive results, making the exchange of test results between laboratories with different methodologies hazardous.
Figures
Comment in
-
Problems in comparing test strategies for detection of anti-Borrelia antibodies.Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):1033-4; author reply 1035-7. doi: 10.1007/s10096-011-1253-7. Epub 2011 Apr 12. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21484251 No abstract available.
Similar articles
-
Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre.Ticks Tick Borne Dis. 2018 Mar;9(3):594-597. doi: 10.1016/j.ttbdis.2017.12.014. Epub 2017 Dec 24. Ticks Tick Borne Dis. 2018. PMID: 29422448
-
Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.Pathology. 2016 Apr;48(3):251-6. doi: 10.1016/j.pathol.2016.02.004. Epub 2016 Mar 5. Pathology. 2016. PMID: 27020501
-
Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.J Clin Microbiol. 2005 Aug;43(8):3602-9. doi: 10.1128/JCM.43.8.3602-3609.2005. J Clin Microbiol. 2005. PMID: 16081885 Free PMC article.
-
Diagnosis of lyme borreliosis in europe.Vector Borne Zoonotic Dis. 2003 Winter;3(4):215-27. doi: 10.1089/153036603322662200. Vector Borne Zoonotic Dis. 2003. PMID: 14733674 Review.
-
Microbiological diagnosis in Lyme borreliosis.Int J Med Microbiol. 2002 Jun;291 Suppl 33:114-9. doi: 10.1016/s1438-4221(02)80022-4. Int J Med Microbiol. 2002. PMID: 12141735 Review.
Cited by
-
Classical Borrelia Serology Does Not Aid in the Diagnosis of Persistent Symptoms Attributed to Lyme Borreliosis: A Retrospective Cohort Study.Life (Basel). 2023 May 6;13(5):1134. doi: 10.3390/life13051134. Life (Basel). 2023. PMID: 37240779 Free PMC article.
-
Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany.Parasit Vectors. 2022 Jul 4;15(1):241. doi: 10.1186/s13071-022-05354-z. Parasit Vectors. 2022. PMID: 35786209 Free PMC article.
-
Borrelia burgdorferi Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12.Infect Immun. 2022 Mar 17;90(3):e0055821. doi: 10.1128/iai.00558-21. Epub 2022 Feb 7. Infect Immun. 2022. PMID: 35130450 Free PMC article.
-
Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update.Parasit Vectors. 2021 Dec 4;14(1):596. doi: 10.1186/s13071-021-05099-1. Parasit Vectors. 2021. PMID: 34863277 Free PMC article.
-
Immunoreactivity of Polish Lyme Disease Patient Sera to Specific Borrelia Antigens-Part 1.Diagnostics (Basel). 2021 Nov 21;11(11):2157. doi: 10.3390/diagnostics11112157. Diagnostics (Basel). 2021. PMID: 34829504 Free PMC article.
References
-
- Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O’Connell S, Ornstein K, Strle F, Gray J. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011;17(1):69–79. doi: 10.1111/j.1469-0691.2010.03175.x. - DOI - PubMed
-
- Wilske B, Zöller L, Brade V, Eiffert H, Göbel UB, Stanek G, Pfister HW. MiQ-12 Lyme-Borreliose (English Internet Version) In: Mauch H, Lütticken R, Gatermann S, editors. Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. München Jena: Urban & Fisher Verlag; 2000.
-
- Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoërsdorff A, Blanco JR, Caruso G, Cinco M, Fournier PE, Francavilla E, Jensenius M, Kazar J, Laferl H, Lakos A, Lotric Furlan S, Maurin M, Oteo JA, Parola P, Perez-Eid C, Peter O, Postic D, Raoult D, Tellez A, Tselentis Y, Wilske B. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10(12):1108–1132. doi: 10.1111/j.1469-0691.2004.01019.x. - DOI - PubMed
-
- Liang FT, Steere AC, Marques AR, Johnson BJ, Miller JN, Philipp MT. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol. 1999;37(12):3990–3996. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
